spacer
spacer
Go to PDB code: 
protein links
Hormone/growth factor PDB id
1zkz
Jmol
Contents
Protein chain
107 a.a. *
Waters ×40
* Residue conservation analysis
PDB id:
1zkz
Name: Hormone/growth factor
Title: Crystal structure of bmp9
Structure: Growth/differentiation factor 2. Chain: a. Fragment: growth/differentiation factor 2, residues 320-429 synonym: gdf-2, bone morphogenetic protein 9, bmp-9. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: gdf2, bmp9. Expressed in: cricetulus griseus. Expression_system_taxid: 10029. Expression_system_tissue: ovary cells.
Biol. unit: Dimer (from PDB file)
Resolution:
2.33Å     R-factor:   0.233     R-free:   0.272
Authors: M.A.Brown,Q.Zhao,K.A.Baker,C.Naik,C.Chen,L.Pukac,M.Singh,T.T Y.Parice,A.Mahoney,V.Roschke,I.Sanyal,S.Choe
Key ref:
M.A.Brown et al. (2005). Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem, 280, 25111-25118. PubMed id: 15851468 DOI: 10.1074/jbc.M503328200
Date:
04-May-05     Release date:   24-May-05    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q9UK05  (GDF2_HUMAN) -  Growth/differentiation factor 2
Seq:
Struc:
429 a.a.
107 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   1 term 
  Biochemical function     growth factor activity     1 term  

 

 
DOI no: 10.1074/jbc.M503328200 J Biol Chem 280:25111-25118 (2005)
PubMed id: 15851468  
 
 
Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
M.A.Brown, Q.Zhao, K.A.Baker, C.Naik, C.Chen, L.Pukac, M.Singh, T.Tsareva, Y.Parice, A.Mahoney, V.Roschke, I.Sanyal, S.Choe.
 
  ABSTRACT  
 
Bone morphogenetic proteins (BMPs), a subset of the transforming growth factor (TGF)-beta superfamily, regulate a diverse array of cellular functions during development and in the adult. BMP-9 (also known as growth and differentiation factor (GDF)-2) potently induces osteogenesis and chondrogenesis, has been implicated in the differentiation of cholinergic neurons, and may help regulate glucose metabolism. We have determined the structure of BMP-9 to 2.3 A and examined the differences between our model and existing crystal structures of other BMPs, both in isolation and in complex with their receptors. TGF-beta ligands are translated as precursors, with pro-regions that generally dissociate after cleavage from the ligand, but in some cases (including GDF-8 and TGF-beta1, -2, and -3), the pro-region remains associated after secretion from the cell and inhibits binding of the ligand to its receptor. Although the proregion of BMP-9 remains tightly associated after secretion, we find, in several cell-based assays, that the activities of BMP-9 and BMP-9.pro-region complex were equivalent. Activin receptor-like kinase 1 (ALK-1), an orphan receptor in the TGF-beta family, was also identified as a potential receptor for BMP-9 based on surface plasmon resonance studies (BIAcore) and the ability of soluble ALK-1 to block the activity of BMP-9.pro-region complex in cell-based assays.
 
  Selected figure(s)  
 
Figure 1.
FIG. 1. Structure of BMP-9. A, Ribbon diagram of BMP-9, showing finger regions 1 and 2 (F1 and F2) and -helix 3 ( 3). The pre-helix loop, which likely encodes specificity determinants, is colored red. C, C terminus; N, N terminus. B, overlay of BMP-9 (blue) and BMP-2 (pink) with BMPR-IA ectodomain. Residues of BMPR-IA within 4.0 Å of BMP-2 are shaded green (36). The carboxyl-terminal residue of BMPR-IA ectodomain is shaded yellow. C, overlay of BMP-9 (blue) and BMP-7 (green) with ActR-II ectodomain. Residues of ActR-II within 4.0 Å of BMP-2 are shaded red (28). The carboxyl-terminal residues of ActR-II ectodomain are shaded yellow. B and C were produced with DINO software (www.dino3d.org).
Figure 2.
FIG. 2. Sequence alignment of BMP-9, BMP-2, BMP-7, BMP-6, and GDF-8. Pro-regions are boxed and shaded gray, furin cleavage sites at the end of each pro-region are boxed in blue. Regions of type II receptor binding are boxed and shaded green (28), regions of type I receptor binding are boxed and shaded purple (27), and conserved cysteines are shaded yellow. Profiles of structural similarity determined by STAMP (34) are boxed in gray. Amino-terminal signal sequences of each protein were omitted from the alignment. Ligands and pro-regions were aligned separately with ClustalW (35).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2005, 280, 25111-25118) copyright 2005.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20554873 A.C.Schnitzler, T.J.Mellott, I.Lopez-Coviella, Y.N.Tallini, M.I.Kotlikoff, M.T.Follettie, and J.K.Blusztajn (2010).
BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons.
  J Neurosci, 30, 8221-8228.  
20545624 C.C.Rider, and B.Mulloy (2010).
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists.
  Biochem J, 429, 1.  
20674464 J.W.Lowery, and M.P.de Caestecker (2010).
BMP signaling in vascular development and disease.
  Cytokine Growth Factor Rev, 21, 287-298.  
19762341 K.Miyazono, Y.Kamiya, and M.Morikawa (2010).
Bone morphogenetic protein receptors and signal transduction.
  J Biochem, 147, 35-51.  
19804412 A.Hauburger, S.von Einem, G.K.Schwaerzer, A.Buttstedt, M.Zebisch, M.Schräml, P.Hortschansky, P.Knaus, and E.Schwarz (2009).
The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.
  FEBS J, 276, 6386-6398.  
19996292 B.Herrera, M.van Dinther, P.Ten Dijke, and G.J.Inman (2009).
Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
  Cancer Res, 69, 9254-9262.  
19222702 F.Chaverneff, and J.Barrett (2009).
Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress.
  J Neurochem, 109, 733-743.  
19493693 H.Senta, H.Park, E.Bergeron, O.Drevelle, D.Fong, E.Leblanc, F.Cabana, S.Roux, G.Grenier, and N.Faucheux (2009).
Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations.
  Cytokine Growth Factor Rev, 20, 213-222.  
19926516 J.Nickel, W.Sebald, J.C.Groppe, and T.D.Mueller (2009).
Intricacies of BMP receptor assembly.
  Cytokine Growth Factor Rev, 20, 367-377.  
19193648 K.L.Walton, Y.Makanji, M.C.Wilce, K.L.Chan, D.M.Robertson, and C.A.Harrison (2009).
A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands.
  J Biol Chem, 284, 9311-9320.  
19502096 L.David, J.J.Feige, and S.Bailly (2009).
Emerging role of bone morphogenetic proteins in angiogenesis.
  Cytokine Growth Factor Rev, 20, 203-212.  
19910235 M.H.Alaoui-Ismaili, and D.Falb (2009).
Design of second generation therapeutic recombinant bone morphogenetic proteins.
  Cytokine Growth Factor Rev, 20, 501-507.  
18033309 D.Sheyn, N.Kimelman-Bleich, G.Pelled, Y.Zilberman, D.Gazit, and Z.Gazit (2008).
Ultrasound-based nonviral gene delivery induces bone formation in vivo.
  Gene Ther, 15, 257-266.  
18339631 G.Sengle, N.L.Charbonneau, R.N.Ono, T.Sasaki, J.Alvarez, D.R.Keene, H.P.Bächinger, and L.Y.Sakai (2008).
Targeting of bone morphogenetic protein growth factor complexes to fibrillin.
  J Biol Chem, 283, 13874-13888.  
18621057 G.Sengle, R.N.Ono, K.M.Lyons, H.P.Bächinger, and L.Y.Sakai (2008).
A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7.
  J Mol Biol, 381, 1025-1039.  
18023475 M.E.Marquis, E.Lord, E.Bergeron, L.Bourgoin, and N.Faucheux (2008).
Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9.
  Biomaterials, 29, 1005-1016.  
18293427 P.C.Bessa, M.Casal, and R.L.Reis (2008).
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts).
  J Tissue Eng Regen Med, 2, 1.  
17496203 D.Liu, J.Wang, B.Kinzel, M.Müeller, X.Mao, R.Valdez, Y.Liu, and E.Li (2007).
Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity.
  Blood, 110, 1502-1510.  
16904831 K.Pardali, and A.Moustakas (2007).
Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
  Biochim Biophys Acta, 1775, 21-62.  
  17456754 L.Umans, L.Cox, M.Tjwa, V.Bito, L.Vermeire, K.Laperre, K.Sipido, L.Moons, D.Huylebroeck, and A.Zwijsen (2007).
Inactivation of Smad5 in endothelial cells and smooth muscle cells demonstrates that Smad5 is required for cardiac homeostasis.
  Am J Pathol, 170, 1460-1472.  
17617550 X.Dong, Q.Wang, T.Wu, and H.Pan (2007).
Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface.
  Biophys J, 93, 750-759.  
16482217 A.E.Harrington, S.A.Morris-Triggs, B.T.Ruotolo, C.V.Robinson, S.Ohnuma, and M.Hyvönen (2006).
Structural basis for the inhibition of activin signalling by follistatin.
  EMBO J, 25, 1035-1045.
PDB codes: 2arp 2arv
16594992 A.Lux, F.Salway, H.K.Dressman, G.Kröner-Lux, M.Hafner, P.J.Day, D.A.Marchuk, and J.Garland (2006).
ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression.
  BMC Cardiovasc Disord, 6, 13.  
17125150 R.L.Rich, and D.G.Myszka (2006).
Survey of the year 2005 commercial optical biosensor literature.
  J Mol Recognit, 19, 478-534.  
16831902 V.Rosen (2006).
BMP and BMP inhibitors in bone.
  Ann N Y Acad Sci, 1068, 19-25.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.